Zhiyong, Ji,
Yeping, Ling,
Pingbo, Chen,
Meng, Yuxiao,
Xu, Shancai,
Wu, Pei,
Wang, Chunlei,
Ilyasova, Tatiana,
Sun, Bowen,
Shi, Huaizhang (2023) of recurrent
serious ischemic events despite standard medical
therapy, has been clinically
challenging. A
Beilerli, A.,
Kudriashov, V.,
Sufianov, A.,
Kostin, A.,
Begliarzade, S.,
Ilyasova, T.,
Liang, Ya.,
Mukhamedzyanov, A.,
Beylerli, O. (2023) resistance and promising directions for targeted
therapy. This review presents the results of scientific
in the expression of miRNAs)
and designing their targeted
therapy using specific miRNAs as targets. This article
, it is necessary to develop an effective
therapy for NF1. The effectiveness of complex
therapy of NF1 with use